Associated Banc-Corp’s AngioDynamics ANGO Stock Holding History

Associated Banc-Corp’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-198	Closed	-$2K	–	946
2020 Q1	$2K	Buy	+198	New	+$2.49K	﹤0.01%	516

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Associated Banc-Corp's ANGO Position: Q2 2020 in Review

Associated Banc-Corp sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 198 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in ANGO in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Associated Banc-Corp reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
Associated Banc-Corp sold 198 AngioDynamics shares in Q2 2020, an estimated $2K.
Associated Banc-Corp first reported a position in AngioDynamics in Q1 2020 and held it in 1 quarter.
Associated Banc-Corp's AngioDynamics position peaked at $2K in Q1 2020.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Associated Banc-Corp's 13F filing for Q2 2020, filed 14 Aug 2020.